Improving access to early cancer trials for underrepresented groups
Increasing Access and Participation to Early Phase Clinical Trials to the Underrepresented Populations
This study is working to make it easier for minority and underserved communities to join early cancer treatment trials, so they can access new therapies that could save lives, while also making sure these treatments are tested on a diverse group of people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10862992 on NIH RePORTER |
What this research studies
This research aims to enhance access and participation in early phase clinical trials for minority and underserved populations, particularly in cancer treatment. It focuses on developing sustainable strategies to engage these groups, ensuring they can access potentially life-saving therapies that are not yet commercially available. The project will utilize lessons learned from previous initiatives to create effective outreach and support mechanisms, addressing the complexities of early phase trials that often limit participation. By increasing representation in these trials, the research seeks to ensure that new cancer therapies are evaluated for their effectiveness across diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include minority and underserved individuals diagnosed with cancer who may benefit from early phase clinical trials.
Not a fit: Patients who are not diagnosed with cancer or those who do not belong to underrepresented populations may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and outcomes for underrepresented populations.
How similar studies have performed: Previous initiatives have shown success in increasing participation of underrepresented groups in clinical trials, indicating that this approach has potential.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Baranda, Joaquina C — University of Kansas Medical Center
- Study coordinator: Baranda, Joaquina C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.